Invivo Therapeutics - Articles and news items


InVivo Therapeutics announces uplisting to Nasdaq

Industry news / 16 April 2015 / Victoria White

InVivo Therapeutics Holdings Corp. (NVIV) has announced that its common stock has been approved to begin trading on The Nasdaq Capital Market…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...